A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, November 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,274 followers.

RT @JournalofExper1: New!🔥 A novel dual epigenetic approach targeting #BETproteins and HDACs in Group 3 (#MYC-driven) #Medulloblastoma Fu…

A novel dual epigenetic approach targeting #BETproteins and HDACs in Group 3 (#MYC-driven) #Medulloblastoma Full text⏬ https://t.co/89ZJoScrCF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.